Role of MDSCs and Cancer Stem Cells and Their Cross Talks in NSCLC
Not yet recruiting
- Conditions
- Lung NeoplasmsMyeloid-Derived Suppressor CellsImmunosuppression
- Registration Number
- NCT06024226
- Lead Sponsor
- University Hospital, Bordeaux
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not yet recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Inclusion Criteria:<br><br> - consecutive patients<br><br> - lung carcinoma surgically treated by surgery only<br><br>Exclusion Criteria:<br><br> - patient receiving chemotherapy, radiotherapy or immunotherapy in the neoadjuvant<br> setting (all objectives)<br><br> - patient with concomitant or previous cancer (in the 2 years)
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparative analysis of the modifications of phenotype and functions of lung cancer cell lines when exposed to MDSC extracted from patient tumor tissue
- Secondary Outcome Measures
Name Time Method